Fed-batch operation for the production of t-PA using Chinese Hamster Ovary
(CHO) cells was optimized using serial and parallel experimentation. The fe
ed, an isotonic concentrate, was improved to obtain 2- to 2.5-foId increase
s in integrated viable cell days versus batch. With a low glucose inoculum
train, the viability index was further increased up to 4.5-fold. Hydrolysat
es were substituted for the amino acid portion of the concentrate with no s
ignificant change in fed-batch results. The concentrate addition rate was b
ased on a constant 4 pmol/cell(.)day glucose uptake rate that maintained a
relatively constant glucose concentration (approximately 3 mM). Increased v
iable cell indices did not lead to concomitant increases in t-PA concentrat
ions compared to batch. The fed-batch concentrate and feeding strategy were
shown to be effective in hybridoma culture, where a 4-fold increase in via
ble cell index yielded a 4-fold increase in antibody concentration. The hal
f-life of t-PA decreased from 43 to 15 days with decreasing cell viability
(from 92% to 71%), but this was not sufficient to explain the apparent t-PA
threshold. Instead, the CHO results were explained by a reduction in t-PA
production at higher extracellular t-PA concentrations that limited the fed
-batch maximum at 35 mg/L for the cell line investigated. Analysis of both
the total and t-PA mRNA levels revealed no response to increasing extracell
ular t-PA concentrations upon exogenous additions. Instead, intracellular t
-PA levels were increased, revealing a possible secretory pathway limitatio
n. A new reactor configuration was developed using an acoustic filter to re
tain the cells in the reactor while an ultrafiltration module stripped t-PA
from the clarified medium before the permeate was returned to the reactor.
By adding this harvesting step, the t-PA fed-batch production was increase
d over 2-fold, up to a yield of 80 mg/L.